<<It borders on the scandalous that cervical cancer, among the few cancers that are preventable, kills 310,000 women a year worldwide. In 2007, 11,150 women in the U.S. were diagnosed with it. Half of them had not had a recent Pap test. Another third did get tested but got false negatives from the 65-year-old Papanicolaou biopsy. The Pap test is valuable, having cut the rate of cervical cancer by 70%, but it is archaic. It calls on a lab technician or machine to peer at a daub of cervical cells under a microscope to spot the abnormal precancerous ones. This artisanal approach yields false negatives between 13% and 45% of the time.>>
doesn't border on the scandalous, it borders on the criminal
<<Ellen Sheets, chief medical officer of Pap maker Hologic (nasdaq: HOLX - news - people ), says that, while the Pap does produce more false negatives than the HPV test, it produces fewer false positives. "We believe your best bet is to get the Pap smear so you know what's wrong today, not find out what might go wrong in the future."
Other clinicians disagree. "The time has come that we need to make a conversion [to the HPV test]. It would be doing women a disservice not to," says Cosette Wheeler, a University of New Mexico School of Medicine professor who has spent her career studying HPV.>>
she should be ashamed of herself...formerly a respected academic at Brigham i think and now she is exhibiting "Ho" logic if you ask me....everyone has their price
i'd almost posit that qgen is in play except that there isn't any options activity to speak of...serious strength here
yes, Yahoo had a story on their site about most overvalued stocks, and this story was listed for QGEN. However, anyone reading the story could see it WASN'T one of the four discussed, but was referenced in the story as a competitor of one of the four most overvalued...so , realizing most people shoot and ask later, some smart people sold a few shares to drive the price down in PM hoping to catch a few upon market open... and, they did